Effects of a polyelectrolyte additive on the selective dialysis membrane permeability for low-molecular-weight proteins

Nephrology Dialysis Transplantation

Volumn 22, Issue 2, 2007, Pages 491-499

  Krieter, Detlef H ^a   Morgenroth, Andreas ^b   Barasinski Artur, A ^a   Lemke, orst Dieter ^c   Schuster, Oliver ^c   von Harten, Bodo ^c   Wanner, Christoph ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Dialysis Center   (Germany)

^c Membrana GmbH   (Germany)

Author keywords

Biocompatibility; Dialysis membrane; End stage renal disease; Haemodialysis; Low molecular weight protein removal; Polyelectrolyte additive

Indexed keywords

BETA 2 MICROGLOBULIN; COMPLEMENT COMPONENT C5A; CYSTATIN C; CYTOCHROME C; ELASTASE; MYELOPEROXIDASE; MYOGLOBIN; POLYELECTROLYTE; POLYSULFONE; RETINOL BINDING PROTEIN; SERUM ALBUMIN; THROMBIN ANTITHROMBIN COMPLEX; WATER;

ADULT; AGED; ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; CHEMICAL MODIFICATION; CLINICAL TRIAL; COMPLEMENT ACTIVATION; CONSTANTS AND COEFFICIENTS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIALYSIS MEMBRANE; FEMALE; HUMAN; IN VITRO STUDY; LEUKOPENIA; MALE; MEMBRANE PERMEABILITY; MOLECULAR WEIGHT; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; RANDOMIZED CONTROLLED TRIAL; SHEEP; TREATMENT OUTCOME;

ANIMALS; BIOCOMPATIBLE MATERIALS; CROSS-OVER STUDIES; DIALYSIS SOLUTIONS; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; PLASTICS; POLYMERS; PROSPECTIVE STUDIES; PROTEINS; RENAL DIALYSIS; SHEEP; SULFONES; TREATMENT OUTCOME;

EID: 33846671206     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl610     Document Type: Article

References (27)

1. Vanholder R, Glorieux G, De Smet R et al. New insights in uremic toxins. Kidney Int 2003; 63 [Suppl 84]: S6-S10
2. Krieter DH, Canaud B. High permeability of dialysis membranes: What is the limit of albumin loss? Nephrol Dial Transplant 2003; 18: 651-654
3. Scribner BH, Babb AL. Evidence for toxins of "middle" molecular weight. Kidney Int 1975; [Suppl 3]: 349-351
4. Kazama JJ, Maruyama H, Gejyo F. Reduction of circulating beta2-microglobulin level for the treatment of dialysis-related amyloidosis. Nephrol Dial Transplant 2001; 16 [Suppl 4]: 31-35
5. Locatelli F, Manzoni C, Di Filippo S. The importance of convective transport. Kidney Int 2002; [Suppl 80]: S115-S120
6. Canaud B, Bragg-Gresham JL, Marshall MR et al. Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int 2006; 69: 2087-2093
7. Jirka T, Cesare S, Di Benedetto A et al. The impact of on-line haemodiafiltration (HDF) on patient survival: Results from a large network database. Nephrol Dial Transplant 2005; 20 [Suppl 5]: 18-19
8. Cheung AK, Rocco MV, Yan G et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: Results of the HEMO study. J Am Soc Nephrol 2006; 17: 546-555
9. Bammens B, Evenepoel P, Keuleers H et al. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 2006; 69: 1081-1087
10. Ward RA. Protein-leaking membranes for hemodialysis: A new class of membranes in search of an application? J Am Soc Nephrol 2005; 16: 2421-3024
11. Ronco C, Bowry S. Nanoscale modulation of the pore dimensions, size distribution and structure of a new polysulfone-based high-flux dialysis membrane. Int J Artif Organs 2001; 24: 726-735
12. Bowry SK, Ronco C. Surface topography and surface elemental composition analysis of Helixone, a new high-flux polysulfone dialysis membrane. Int J Artif Organs 2001; 24: 757-764
13. Werner C, Jacobasch HJ, Reichelt G. Surface characterization of hemodialysis membranes based on streaming potential measurements. J Biomater Sci Polym Ed 1995; 7: 61-76
14. Henderson LW. Biophysics of ultrafiltration and hemofiltration. In: Jacobs C, Kjellstrand CM, Koch KM, Winchester JF, eds. Replacement of Renal Function by Dialysis, 4th edn, Kluwer Academic Publishers, Dordrecht/Boston/London: 1996; 114-145
15. Sargent JA, Gotch FA. Principles and biophysics of dialysis. In: Jacobs C, Kjellstrand CM, Koch KM, Winchester JF, eds. Replacement of Renal Function by Dialysis, 4th edn, Kluwer Academic Publishers, Dordrecht/ Boston/London: 1996; 34-102
16. Krieter DH, Grude M, Lemke HD et al. Anaphylactoid reactions during hemodialysis in sheep are ACE inhibitor dose-dependent and mediated by bradykinin. Kidney Int 1998; 53:1026-1035
17. Hoenich NA, Frost TH, Kerr DNS. Dialysers. In: Drukker F, Parsons FM, Maher JF, eds. Replacement of Renal Function by Dialysis, Martinus Nijhoff Publishers, Hague/Boston/London: 1979;80-124
18. Basile G, Casino F, Lopez T. Percent reduction in blood urea concentration during dialysis estimates Kt/V in a simple and accurate way. Am J Kidney Dis 1990; 15: 40-45
19. 2-microglobulin concentration after cuprophane haemodialysis. Lancet 1987; 1: 628-629
20. Hakim RM, Held PJ, Stannard DC et al. Effect of the dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int 1996; 50: 566-570
21. 2-mikroglobulin. Long-term clinical observations. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 49-54
22. Krieter DH, Falkenhain S, Chalabi L et al. Clinical cross-over comparison of mid-dilution hemodiafiltration using a novel dialyzer concept and post-dilution hemodiafiltration,. Kidney Int 2005; 67: 349-356
23. Legallais C, Canaud B, Delumeau J et al. Use of a mass transfer model to analyze membrane changes during clinical post-dilution hemodiafiltration (Abstract). Nephrol Dial Transplant 2005; 20 [Suppl 5]: 335
24. Klingel R, Schaefer M, Schwarting A et al. Comparative analysis of procoagulatory activity of haemodialysis, haemofiltration and haemodiafiltration with a polysulfone membrane (APS) and with different modes of enoxaparin anticoagulation. Nephrol Dial Transplant 2004; 19: 164-170
25. Wu CC, Chen JS, Wu WM et al. Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes. Nephrol Dial Transplant 2005; 20: 1134-1139
26. Ono K, Ueki K, Inose K et al. Plasma levels of myeloperoxidase and elastase are differentially regulated by hemodialysis membranes and anticoagulants. Res Commun Mol Pathol Pharmacol 2000; 108: 341-349
27. Cheung AK. Biocompatibility of hemodialysis membranes. J Am Soc Nephrol 1990; 1: 150-161